Burleson & Co’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$3.35M Buy
6,310
+531
+9% +$281K 0.83% 36
2022
Q3
$2.92M Buy
5,779
+223
+4% +$117K 0.63% 40
2022
Q2
$2.85M Sell
5,556
-97
-2% -$48.7K 0.62% 41
2022
Q1
$2.88M Buy
5,653
+5,350
+1,766% +$2.58M 0.46% 51
2021
Q4
$152K Buy
303
+1
+0.3% +$453 0.02% 154
2021
Q3
$118K Hold
302
0.02% 158
2021
Q2
$121K Hold
302
0.02% 157
2021
Q1
$113K Buy
+302
New +$105K 0.02% 151

Other funds holding UNH

Burleson & Co's UNH Position: Q4 2022 in Review

Burleson & Co increased its UnitedHealth (UNH) stake by 9.2% in Q4 2022, buying an estimated $281K and bringing the position to 6,310 shares worth $3.35M. The position accounts for 0.83% of the portfolio, ranked #36.

Burleson & Co first reported a position in UNH in Q1 2021 and has held it in 8 quarters since. 3,157 funds tracked by Wall St. Rank hold UNH as of Q4 2022.

  • Burleson & Co held 6,310 shares of UnitedHealth worth $3.35M as of Q4 2022.
  • Burleson & Co bought 531 UnitedHealth shares in Q4 2022, an estimated $281K.
  • UnitedHealth made up 0.83% of Burleson & Co's portfolio in Q4 2022, its #36 holding.
  • Burleson & Co first reported a position in UnitedHealth in Q1 2021 and has held it in 8 quarters since.
  • 3,157 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.